%PDF-1.4
%
4 0 obj
<>
endobj
5 0 obj
<>stream
Princz A.; Tavernarakis N.
SUMOylation in Neurodegenerative Diseases
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.<br />
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.<br />
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Posttranslational modifications are ubiquitous regulators of cellular processes. The regulatory role of SUMOylation, the attachment of a small ubiquitin-related modifier to a target protein, has been implicated in fundamental processes like cell division, DNA damage repair, mitochondrial homeostasis, and stress responses. Recently, it is gaining more attention in drug discovery as well. As life expectancy keeps rising, more individuals are at risk for developing age-associated diseases. This not only makes a person’s life uncomfortable, but it also places an economic burden on society. Therefore, finding treatments for age-related diseases is an important issue. Understanding the basic mechanisms in the cell under normal and disease conditions is fundamental for drug discovery. There is an increasing number of reports showing that the ageing process could be influenced by SUMOylation. Similarly, SUMOylation is essential for proper neuronal function. In this review we summarize the latest results regarding the connection between SUMOylation and neurodegenerative diseases. We highlight the significance of specific SUMO target proteins and the importance of SUMO isoform specificity.
Ageing
Alzheimer’s disease
Huntington’s disease
Neurodegeneration
Neuron
Parkinson’s disease
SUMO
endstream
endobj
6 0 obj
<>stream
x+ |
endstream
endobj
7 0 obj
<>stream
x}
0y9i6Mѣ`!mhMHugf
wrx1$94k2I =,{}jCqO15wGH Gcn[[:hJ;W?B\(tE(S&SYZ
zE>
endstream
endobj
8 0 obj
<>stream
x+ |
endstream
endobj
9 0 obj
<>stream
x}
0y9i6Mѣ`!mhMHugf
wVrxaF%LIshל?Oe@z2Y6}bj4ܶuє0#w;̯5~~EPTE?*萋P0LBcҵ2$I>
endstream
endobj
10 0 obj
<>stream
x+ |
endstream
endobj
11 0 obj
<>stream
x}K0sC$mڴ7E^+}迷"2,2rM&KDH%tEs$̭>wx8tdjͩ͋aH1wGH Snט[Yh+[=Wۛ?BN\(_0 JLEKZlN>
endstream
endobj
12 0 obj
<>stream
x+ |
endstream
endobj
13 0 obj
<>stream
x}
0y9i6Mѣ`!mhMHugf
w6FW[,J̯9$dl>1!%hmmoElף)aGw_]gk
9sT0!`\#NLfkeH6 R4>
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
x}
0y9i6Mѣ`!mhMHugf
wVrx1$94k2I =,{}jCqO15wGH Gcn[[:hJ;W?B\(tE(S&SYZ
zVd>
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
x}K0sC$5mڛGB>hM}۔"β|Hu0J&ǂJ3B9WFsfQ,/rs}zcn~@J0}mEkMף)gfuXlgj
9s
T0x}.|x0a21v/YMA/*>q
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
x}K0sC$5mڛGB>hM}۔"β|Hu0\Jf%#fs"Hͣ>7Y^8 a0q܋֚GSB"밼YrBQ`\ad"b_6^\>u
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
x}O@)ޱA]T6Jɵ?~\
d:RDH%tIxHk}!n+9UM~,8)Q0q܋֚GSB"ﰸYrBQ`\Qd*l7_֚d^>y
endstream
endobj
22 0 obj
<>stream
x+ |
endstream
endobj
23 0 obj
<>stream
x}K0sC$5mڛGB>hM}۔"β|Hu0